Dr Bivas-Benita, a senior Researcher at KI Research Institute in Israel, said: “Findings were similar across the wild-type, Alpha and Delta covid-19 variants.”
She added: “Our study suggests that mild Covid-19 patients are at risk for a small number of health outcomes and most of them are resolved within a year from diagnosis.
“Importantly, the risk for lingering dyspnoea was reduced in vaccinated patients with breakthrough infection compared with unvaccinated people, while risks of all other outcomes were comparable.”
If you are struggling to cope with the symptoms of long Covid, the NHS advises speaking to your doctor who could refer you to a long Covid service.
This story originally Appeared on Express.co.uk